ABBV vs DVA
By Alex · Tickerpine
AbbVie Inc. vs DaVita Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | DVA |
|---|---|---|
| Price | $295.03 | $174.56 |
| Market cap | $521.50B | $10.98B |
| P/E ratio | 50.7 | 13.2 |
| ROE | — | 96.79% |
| Profit margin | 15.67% | 6.49% |
| Revenue growth | 10.30% | 4.60% |
| Dividend yield | 2.35% | 0.00% |
| Beta | 0.19 | 0.86 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs DVA in plain English
- ABBV is the bigger company — about 47.5× the market cap of DVA.
- DVA is cheaper on earnings (P/E 13.2 vs 50.7).
- ABBV is growing revenue faster (10% vs 5%).
- ABBV pays a dividend (2.35%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
DVA return calculator
See what $1,000 in DaVita Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.